I13 Antimicrobial Susceptibility Testing (AST) of Invasive H

[NCEZID] Public Health Laboratory Testing for Emerging Antibiotic Resistance and Fungal Threats

Attachment 2m_I.13- AST OF INVASIVE H. INFLUENZAE IN JURISDICTION- AEPMR

OMB: 0920-1310

Document [docx]
Download: docx | pdf

Form Approved

OMB Control No.: 0920-1310

Expiration date: XX/XX/XXXX


Annual Evaluation and Performance Measurement Report (I.13- ANTIMICROBIAL SUSCEPTIBILITY TESTING (AST) OF INVASIVE HAEMOPHILUS INFLUENZAE (H. INFLUENZAE) IN JURISDICTION)

Annually, each funded laboratory is required to report to CDC evaluation and performance measures. Data are used to indicate progress made toward program outcomes. These summary reports have to be uploaded to the ELC CAMP at the end of each funding year. Required performance measures are listed below.

  1. Susceptibility of invasive H. influenzae ( HI) isolates using broth microdilution, according to the Clinical & Laboratory Standards Institute (CLSI) guidelines for at least the following 12 antibiotics with QC-passed broth microdilution test results:

Antibiotic:

Total Number (N) of H. influenzae Isolates with QC-passed broth microdilution

  1. Rifampin


  1. Ampicillin


  1. Amoxicillin-clavulanate


  1. Chloramphenicol


  1. Cefotaxime


  1. Ceftriaxone


  1. Cefuroxime


  1. Clarithromycin


  1. Levofloxacin


  1. Meropenem


  1. Tetracycline


  1. Trimethoprim-sulfamethoxazole



  1. Proportion of isolates with AST results reported to submitting sites within 3 weeks of submission:

  1. Numerator: Number of isolates with AST results reported to submitting sites within 3 weeks of submission

  2. Denominator: Number of HI isolates received at AR Lab Network

  3. Calculated: Percentage of isolates with AST results reported to sentinel sites within 3 weeks of submission


  1. Proportion of isolates with AST results reported to CDC-Bacterial Meningitis Laboratory (CDC-BML) quarterly:

a. Numerator: Number of isolates with AST results reported to CDC quarterly.

b. Denominator: Number of HI isolates received at AR Lab Network.

c. Calculated: Percentage of isolates with AST results reported to CDC quarterly.


  1. Proportion of isolates transported to CDC-BML within 6 months:

  1. Numerator: Number of isolates transported to CDC

  2. Denominator: Total number of HI isolates received at AR Lab Network.

  3. Calculated: Percent of isolates transported to CDC within 6 months



Public reporting burden of this collection of information is estimated to average 20 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS H21-8, Atlanta, Georgia 30333; ATTN: PRA 0920-1310


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorSwaray, Masiray (CDC/NCEZID/DHQP/OD) (CTR)
File Modified0000-00-00
File Created2025-01-17

© 2025 OMB.report | Privacy Policy